“A Sensitive Bioanalytical Method Development And Validation Of Pazopanib In Human Plasma By LC-ESI-MS MS”. Journal of Pharmaceutical Negative Results, Nov. 2022, pp. 855-61, https://doi.org/10.47750/pnr.2022.13.S09.102.